Developer docs
API playgroundTry for free, no card

Search company profiles

Thess

Full company profile

uuid00049y4

Namestring
Thess
Legal namestring
Thess Corporate
Websiteurl
thess-corp.fr
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Thess Corporate is a French medical device company headquartered in Montpellier that builds connected products for medication intake security and medical telesurveillance. Its portfolio centers on two complementary devices: Thess Device, a connected and secure smart medication box with continuous integrity control, multi-fingerprint authentication (up to nine users), multi-medication management, and roughly one-month battery life; and Thess Monitoring, a configurable telemonitoring platform that meets French health-IT interoperability criteria (Agence Numérique Santé), integrates with Electronic Patient Records, and enables remote real-time medication dose adjustment by healthcare providers. A specialized variant, Thess Monitoring Antalgeek, extends the platform into post-surgical pain monitoring (ERAS and ambulatory surgery pathways). Thess was created in 2021 by La Sas La Valériane, which contributed its IT branch and the Thess Device research program with French patent FR3125962 in 2022.

The company operates a B2B enterprise model targeting healthcare institutions and clinical professionals rather than direct consumers. Go-to-market is anchored by direct enterprise sales and clinical-study partnerships with French teaching hospitals (CHU Montpellier, CHU Nîmes, CHU Grenoble), cancer networks (Unicancer, Institut de cancérologie du Gard), and dialysis providers (NephroCare), with international validation through Mayo Clinic (USA), NYC Pain Specialists (USA), CHU Montréal (Canada), and an AppMed distribution agreement covering Canada. Revenue combines one-time medical device sales with recurring telemonitoring services; in France, Thess Monitoring is reimbursed by Social Security under code 6654493 for nephrology telemonitoring (chronic renal insufficiency, hemodialysis, peritoneal dialysis, and post-renal transplant care), while other indications (oncology, post-surgical) are supported through clinical studies (Beautify, Prolife, Trace) without disclosed reimbursement. Regulatory status includes ISO 13485:2016 certification (DQS, 2024), CE DM Class IIa under MDR (EU) 2017/745, Convergence certification (2025), and RGPD/GDPR compliance, with industrialization and export supported by France 2030 and EU Next Generation EU public funding.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMontpellier, France
HQ citystring
Montpellier
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
connected medical devices, medication adherence systems, medical telemonitoring, remote patient monitoring, healthcare IT solutions
Industry1 code
PRIMARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Offices of Physicians6211
  • Health Care and Social Assistance62
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Health Services8000
Product category
Connected Medical Devices and Telemonitoring
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales and Telemonitoring Services
TypeSubscription Recurring
Description

Thess generates revenue through the sale of medical devices (Thess Device) and telemonitoring services (Thess Monitoring), with reimbursement from French social security for specific nephrology protocols including Stage IV, Stage V, hemodialysis, peritoneal dialysis, and post-renal transplant care.

thess-corp.fr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Thess Device
Description

Connected and secure medication intake medical device.

thess-corp.fr
+1 more record
Core offering1 text field

Thess Corporate sells connected medical devices (Thess Device) for secure medication intake paired with Thess Monitoring, a configurable medical telesurveillance platform that lets healthcare providers remotely track patient adherence and adjust doses in real time. The portfolio also includes Thess Monitoring Antalgeek, a specialized telesurveillance variant for post-surgical pain monitoring, with the device line certified CE Class IIa under MDR (EU) 2017/745 and reimbursed by French social security for nephrology protocols.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Thess does not detract from human relationships with care teams; care team is actually more present with the technology
+2 more records
Product overview1 text field

Thess Corporate offers a dual-product portfolio centered on digital medical devices for medication management and medical telemonitoring. Thess Device is the connected medication intake system (smart pill organizer) that secures and tracks medication-taking. Thess Monitoring is the accompanying telemonitoring platform that enables healthcare professionals to remotely track patient health and compliance. The two products are designed to work together: Thess Device provides precise compliance monitoring that feeds into Thess Monitoring's dashboard, enabling real-time notifications to care teams and caregivers when patients become non-adherent. A specialized variant, Thess Monitoring Antalgeek, addresses post-surgical pain monitoring.

Product and service3 records
1Thess Device
CategoryConnected medical device
Description

Connected and secure medical device for medication intake. Enables real-time remote dose adjustment, manages multiple medications and dosages, supports up to 9 fingerprints for unlocking, has a one-month battery life on daily use, and maintains international connectivity for patients who travel.

2Thess Monitoring
CategoryMedical telesurveillance software
Description

Configurable medical telesurveillance platform (CE Class IIa medical device) that enables healthcare professionals to remotely monitor patients' health parameters and medication adherence, supports notifications via SMS or email, and integrates with Electronic Patient Record systems.

3Thess Monitoring Antalgeek
CategoryMedical telesurveillance software
Description

Specialized variant of Thess Monitoring dedicated to post-surgical pain monitoring, designed to secure patients' return home and prevent pain chronification after surgical procedures.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-01
Description

Thess Corporate and AppMed entered into a distribution agreement for Thess Monitoring and Thess Device in Canada, marking the company's first formal international distribution partnership.

2Centre Hospitalier de Nîmes
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CHU Nîmes partnered with Thess to pilot Thess Monitoring Antalgeek, a world-first digital medical device for post-surgical pain monitoring. The partnership aims to secure patient return home while preventing chronic pain risk.

thess-corp.fr
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Mayo Clinic in the USA conducted usage experimentation of Thess Device starting in 2023 as part of international clinical validation.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

CHU Montréal in Canada served as a usage experimentation site for Thess Device starting in 2025, supporting international expansion into the Canadian market.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

CHU Grenoble served as a usage experimentation site for Thess Device starting in 2025, validating the technology for medication compliance in French healthcare settings.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

European dialysis network partnership for nephrology telemonitoring services using Thess Monitoring for hemodialysis patients in center and at home settings.

7Unicancer
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with the French cancer center network encompassing 18 comprehensive cancer centers, supporting oncology telemonitoring applications.

thess-corp.fr
8Institut de cancérologie du Gard
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Regional cancer institute partnership for medical telesurveillance using Thess products in oncology treatment protocols.

thess-corp.fr
9CHU Montpellier
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major teaching hospital partnership for medical telesurveillance using Thess products across various therapeutic areas.

thess-corp.fr
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Connected pill dispenser with remote monitoring and reminder functions for chronic and elderly patients, directly comparable to Thess Device's adherence and integrity-control features.

TypeBroad incumbent
Description

Diversified medtech with remote patient monitoring and connected care platforms serving hospitals and home care. Overlaps with Thess Monitoring's telemonitoring platform and EHR integration capabilities.

TypeRegional player
Description

French-connected device company illustrating the trajectory of European connected-device companies built around B2B sales and industrialisation. Relevant as a French tech peer in the same Montpellier/IoT ecosystem (different vertical).

TypeDirect peer
Description

Provides connected medication adherence and RPM solutions for clinical trials and patient monitoring, directly comparable to Thess Monitoring's telemonitoring platform with Electronic Patient Record integration.

TypeEmerging player
Description

Digital health platform offering remote patient monitoring across multiple therapeutic areas including nephrology and oncology. Comparable as a software-focused RPM peer targeting similar clinical use cases.

6Doctolib (télésurveillance)
TypeBroad incumbent
Description

French health-tech incumbent increasingly active in remote consultation and telemonitoring infrastructure for physicians and hospitals. Comparable as the dominant French healthcare software layer Thess must integrate with to scale.

TypeBroad incumbent
Description

Larger healthcare players offering RPM suites that can extend into medication adherence and chronic disease telemonitoring. Comparable as broad incumbents that could bundle or compete against Thess's specialty offering.

TypeDirect peer
Description

Smart pill dispenser with companion app and adherence tracking, a direct product analog to Thess Device in the connected medication-adherence category.

TypeBroad incumbent
Description

Global leader in connected health devices for chronic conditions (sleep apnea, COPD) with strong reimbursement and RPM infrastructure. Comparable as a broad incumbent moving into specialty medication adherence and remote patient monitoring.

10Devinlec / Observa
TypeDirect peer
Description

French-connected medication adherence and telemonitoring providers operating in similar remote patient monitoring and smart pillbox niches. Closely comparable to Thess in product offering and French reimbursement-driven business model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Thess

Connected Medical Devices and Telemonitoringthess-corp.fr

What Thess does

Thess Corporate is a French medical device company headquartered in Montpellier that builds connected products for medication intake security and medical telesurveillance. Its portfolio centers on two complementary devices: Thess Device, a connected and secure smart medication box with continuous integrity control, multi-fingerprint authentication (up to nine users), multi-medication management, and roughly one-month battery life; and Thess Monitoring, a configurable telemonitoring platform that meets French health-IT interoperability criteria (Agence Numérique Santé), integrates with Electronic Patient Records, and enables remote real-time medication dose adjustment by healthcare providers. A specialized variant, Thess Monitoring Antalgeek, extends the platform into post-surgical pain monitoring (ERAS and ambulatory surgery pathways). Thess was created in 2021 by La Sas La Valériane, which contributed its IT branch and the Thess Device research program with French patent FR3125962 in 2022.

The company operates a B2B enterprise model targeting healthcare institutions and clinical professionals rather than direct consumers. Go-to-market is anchored by direct enterprise sales and clinical-study partnerships with French teaching hospitals (CHU Montpellier, CHU Nîmes, CHU Grenoble), cancer networks (Unicancer, Institut de cancérologie du Gard), and dialysis providers (NephroCare), with international validation through Mayo Clinic (USA), NYC Pain Specialists (USA), CHU Montréal (Canada), and an AppMed distribution agreement covering Canada. Revenue combines one-time medical device sales with recurring telemonitoring services; in France, Thess Monitoring is reimbursed by Social Security under code 6654493 for nephrology telemonitoring (chronic renal insufficiency, hemodialysis, peritoneal dialysis, and post-renal transplant care), while other indications (oncology, post-surgical) are supported through clinical studies (Beautify, Prolife, Trace) without disclosed reimbursement. Regulatory status includes ISO 13485:2016 certification (DQS, 2024), CE DM Class IIa under MDR (EU) 2017/745, Convergence certification (2025), and RGPD/GDPR compliance, with industrialization and export supported by France 2030 and EU Next Generation EU public funding.

Thess firmographics

Firmographics
Name
Thess
Legal name
Thess Corporate
Website
https://thess-corp.fr
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Thess industry classification

Industry
Product category
Connected Medical Devices and Telemonitoring
NAICS
Offices of Physicians (6211), Health Care and Social Assistance (62)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Connected medical devices
  • Medication adherence systems
  • Medical telemonitoring
  • Remote patient monitoring
  • Healthcare IT solutions

Where Thess is headquartered

Location

Headquarters

HQ city
Montpellier
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Thess business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales and Telemonitoring Services: Thess generates revenue through the sale of medical devices (Thess Device) and telemonitoring services (Thess Monitoring), with reimbursement from French social security for specific nephrology protocols including Stage IV, Stage V, hemodialysis, peritoneal dialysis, and post-renal transplant care.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Thess product offering

Product offering

Core offering

Thess Corporate sells connected medical devices (Thess Device) for secure medication intake paired with Thess Monitoring, a configurable medical telesurveillance platform that lets healthcare providers remotely track patient adherence and adjust doses in real time. The portfolio also includes Thess Monitoring Antalgeek, a specialized telesurveillance variant for post-surgical pain monitoring, with the device line certified CE Class IIa under MDR (EU) 2017/745 and reimbursed by French social security for nephrology protocols.

Product overview

Thess Corporate offers a dual-product portfolio centered on digital medical devices for medication management and medical telemonitoring. Thess Device is the connected medication intake system (smart pill organizer) that secures and tracks medication-taking. Thess Monitoring is the accompanying telemonitoring platform that enables healthcare professionals to remotely track patient health and compliance. The two products are designed to work together: Thess Device provides precise compliance monitoring that feeds into Thess Monitoring's dashboard, enabling real-time notifications to care teams and caregivers when patients become non-adherent. A specialized variant, Thess Monitoring Antalgeek, addresses post-surgical pain monitoring.

Differentiator

Problem solved

Functional benefit

Brands

  • Thess Device: Connected and secure medication intake medical device.
  • Thess Monitoring

Products and services

  • Thess Device Connected and secure medical device for medication intake. Enables real-time remote dose adjustment, manages multiple medications and dosages, supports up to 9 fingerprints for unlocking, has a one-month battery life on daily use, and maintains international connectivity for patients who travel.
  • Thess Monitoring Configurable medical telesurveillance platform (CE Class IIa medical device) that enables healthcare professionals to remotely monitor patients' health parameters and medication adherence, supports notifications via SMS or email, and integrates with Electronic Patient Record systems.
  • Thess Monitoring Antalgeek Specialized variant of Thess Monitoring dedicated to post-surgical pain monitoring, designed to secure patients' return home and prevent pain chronification after surgical procedures.

Quantifiable outcome

  • Thess does not detract from human relationships with care teams; care team is actually more present with the technology
  • +2 more outcomes

Companies that use Thess

Customer profile

Named customers14 records

Segments3 records

Ideal customer profiles3 records

Thess technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Thess partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and major.

  • AppMedcoreChannel Partner/ Reseller/ Distributor · 1 January 2025Thess Corporate and AppMed entered into a distribution agreement for Thess Monitoring and Thess Device in Canada, marking the company's first formal international distribution partnership.
  • Centre Hospitalier de NîmescoreStrategic or Co-development PartnerCHU Nîmes partnered with Thess to pilot Thess Monitoring Antalgeek, a world-first digital medical device for post-surgical pain monitoring. The partnership aims to secure patient return home while preventing chronic pain risk.
  • Mayo Clinic (USA)majorStrategic or Co-development PartnerMayo Clinic in the USA conducted usage experimentation of Thess Device starting in 2023 as part of international clinical validation.
  • CHU Montréal (Canada)majorStrategic or Co-development PartnerCHU Montréal in Canada served as a usage experimentation site for Thess Device starting in 2025, supporting international expansion into the Canadian market.
  • CHU GrenoblemajorStrategic or Co-development PartnerCHU Grenoble served as a usage experimentation site for Thess Device starting in 2025, validating the technology for medication compliance in French healthcare settings.
  • NephroCaremajorStrategic or Co-development PartnerEuropean dialysis network partnership for nephrology telemonitoring services using Thess Monitoring for hemodialysis patients in center and at home settings.
  • UnicancermajorStrategic or Co-development PartnerPartnership with the French cancer center network encompassing 18 comprehensive cancer centers, supporting oncology telemonitoring applications.
  • Institut de cancérologie du GardcoreStrategic or Co-development PartnerRegional cancer institute partnership for medical telesurveillance using Thess products in oncology treatment protocols.
  • CHU MontpelliercoreStrategic or Co-development PartnerMajor teaching hospital partnership for medical telesurveillance using Thess products across various therapeutic areas.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Thess competitors and assessment

Company assessment

Direct peers

  • MedMinder: Connected pill dispenser with remote monitoring and reminder functions for chronic and elderly patients, directly comparable to Thess Device's adherence and integrity-control features.
  • Hillo (Aparito): Provides connected medication adherence and RPM solutions for clinical trials and patient monitoring, directly comparable to Thess Monitoring's telemonitoring platform with Electronic Patient Record integration.
  • Pillsy (acquired by Becton Dickinson): Smart pill dispenser with companion app and adherence tracking, a direct product analog to Thess Device in the connected medication-adherence category.
  • Devinlec / Observa: French-connected medication adherence and telemonitoring providers operating in similar remote patient monitoring and smart pillbox niches. Closely comparable to Thess in product offering and French reimbursement-driven business model.

Broad incumbents

  • Philips (HealthSuite / RPM): Diversified medtech with remote patient monitoring and connected care platforms serving hospitals and home care. Overlaps with Thess Monitoring's telemonitoring platform and EHR integration capabilities.
  • Doctolib (télésurveillance): French health-tech incumbent increasingly active in remote consultation and telemonitoring infrastructure for physicians and hospitals. Comparable as the dominant French healthcare software layer Thess must integrate with to scale.
  • Bayer/Philips VitalConnect RPM solutions: Larger healthcare players offering RPM suites that can extend into medication adherence and chronic disease telemonitoring. Comparable as broad incumbents that could bundle or compete against Thess's specialty offering.
  • Resmed (MDRP / remote monitoring): Global leader in connected health devices for chronic conditions (sleep apnea, COPD) with strong reimbursement and RPM infrastructure. Comparable as a broad incumbent moving into specialty medication adherence and remote patient monitoring.

Regional players

  • Sencrop: French-connected device company illustrating the trajectory of European connected-device companies built around B2B sales and industrialisation. Relevant as a French tech peer in the same Montpellier/IoT ecosystem (different vertical).

Emerging players

  • Huma (formerly Medopad): Digital health platform offering remote patient monitoring across multiple therapeutic areas including nephrology and oncology. Comparable as a software-focused RPM peer targeting similar clinical use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Thess social profiles

Digital presence

Thess compliance and trust

Trust signal

Compliance4 records

Thess financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Thess leadership team

Management profile

Number of profiles

Profiles5 records

Thess funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Thess M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Thess

What does Thess do?

Thess Corporate sells connected medical devices (Thess Device) for secure medication intake paired with Thess Monitoring, a configurable medical telesurveillance platform that lets healthcare providers remotely track patient adherence and adjust doses in real time. The portfolio also includes Thess Monitoring Antalgeek, a specialized telesurveillance variant for post-surgical pain monitoring, with the device line certified CE Class IIa under MDR (EU) 2017/745 and reimbursed by French social security for nephrology protocols.

Is Thess a public or private company?

Thess is a private company. It is classified as corporate owned and is currently operating.

When was Thess founded?

Thess was founded in 2021. It employs 11 to 50 people.

Where is Thess based?

Thess is headquartered in Montpellier, France, in the Europe region.

How does Thess make money?

One revenue line is on record: medical Device Sales and Telemonitoring Services.

Who are Thess's main competitors?

Direct peers on record are MedMinder, Hillo (Aparito), Pillsy (acquired by Becton Dickinson) and Devinlec / Observa. Broad incumbents are Philips (HealthSuite / RPM), Doctolib (télésurveillance), Bayer/Philips VitalConnect RPM solutions and Resmed (MDRP / remote monitoring). Sencrop is listed as a regional player. Huma (formerly Medopad) is listed as an emerging player.

Does Thess have an API?

No public API is recorded for Thess.

What industry is Thess in?

Thess's product category is Connected Medical Devices and Telemonitoring. Its primary akta.pro industry code is HLACAPAH, Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers). Its NAICS code is 6211 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales